Chiglitazar Sodium Combined With Venetoclax and Azacitidine (CVA) for the Treatment of R/R AML

Abroad (travel likely)RecruitingPHASE1

Conditions

Acute Myeloid Leukemia · Relapse · Refractory AML

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Contact: Study coordinator (Bing Xu) · xubingzhangjian@126.com · 18750918842

Study leads

Bing Xu
Principal Investigator
The First Aiffiliated hosptical of xiamen University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Adoptive T Cell Therapy With DC/AML Fusion Vaccine Plus Decitabine and Venetoclax in AML

Acute Myeloid Leukemia · Acute Myeloid Leukemia, in Relapse

Abroad (travel likely)RecruitingPHASE1

Boston, United States

PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

Acute Myeloid Leukemia · Acute Myeloid Leukemia Refractory · Acute Myeloid Leukemia, in Relapse

Abroad (travel likely)RecruitingPHASE1

Seattle, United States

Study of NMS-03597812 in Adult Patients With Relapsed/Refractory Acute Myeloid Leukemia

Relapsed/Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Duarte, United States · Aurora, United States

Clinical Trial of WBC100 Capsule in Relapsed/Refractory Acute Myeloid Leukemia

AML (Acute Myelogenous Leukemia · Relapsed Acute Myelogenous Leukemia · Refractory Acute Myeloid Leukemia

Abroad (travel likely)RecruitingPHASE1

Hangzhou, China